Albert Kildani | Vice President, Investor Relations and Business Development |
Russell Cox | Chief Executive Officer |
Michael Swanson | Chief Financial Officer and Executive Vice President |
Robert Ashley | Chief Technical Officer and Executive Vice President |
Duane Nash | President |
Laura Chico | Raymond James |
Good day, ladies and gentlemen, and welcome to the Vital Therapies' Second Quarter 2018 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] As a reminder, this conference call may be recorded. I would now like to turn the conference over to Al Kildani.